Literature DB >> 20930058

Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products.

Stephen S Hecht, Irina Stepanov, Dorothy K Hatsukami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20930058      PMCID： PMC3876954          DOI： 10.1136/tc.2010.037648

Source DB:  PubMed          Journal:  Tob Control        ISSN： 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  4 in total

1.  Tobacco-specific nitrosamines in new tobacco products.

Authors:  Irina Stepanov; Joni Jensen; Dorothy Hatsukami; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-04       Impact factor: 4.244

2.  Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.

Authors:  Patricia Richter; Knachelle Hodge; Stephen Stanfill; Liqin Zhang; Clifford Watson
Journal:  Nicotine Tob Res       Date:  2008-11       Impact factor: 4.244

Review 3.  Preformed N-nitroso compounds in foods and beverages.

Authors:  J H Hotchkiss
Journal:  Cancer Surv       Date:  1989

4.  Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.

Authors:  Bengt-Göran Osterdahl; Christer Jansson; Alexandre Paccou
Journal:  J Agric Food Chem       Date:  2004-08-11       Impact factor: 5.279
  4 in total
  7 in total

1.  Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.

Authors:  Andrew B Seidenberg; Olalekan A Ayo-Yusuf; Vaughan W Rees
Journal:  Nicotine Tob Res       Date:  2018-01-05       Impact factor: 4.244

2.  Assessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.

Authors:  Eugene Borgida; Barbara Loken; Allison L Williams; Joseph Vitriol; Irina Stepanov; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2015-01-29       Impact factor: 4.244

Review 3.  Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer.

Authors:  Jian-Min Yuan; Lesley M Butler; Irina Stepanov; Stephen S Hecht
Journal:  Cancer Res       Date:  2014-01-09       Impact factor: 12.701

Review 4.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

5.  (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats.

Authors:  Silvia Balbo; Sandra James-Yi; Charles S Johnson; Michael G O'Sullivan; Irina Stepanov; Mingyao Wang; Dipankar Bandyopadhyay; Fekadu Kassie; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2013-05-13       Impact factor: 4.944

6.  Levels of (S)-N'-nitrosonornicotine in U.S. tobacco products.

Authors:  Irina Stepanov; Katrina Yershova; Steven Carmella; Pramod Upadhyaya; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2012-12-03       Impact factor: 4.244

7.  Clinical and biochemical studies support smokeless tobacco's carcinogenic potential in the human oral cavity.

Authors:  Susan R Mallery; Meng Tong; Gregory C Michaels; Amber R Kiyani; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.